Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Molecular Sciences|January 10, 2026
Redox Modulation in Hepatic Fibrosis: Translating NOX1/4 Inhibition to TherapyGhaith K Mansour, Ahmad W Hajjar, Irene Marafini, et al.International Journal of Molecular Sciences|December 30, 2025
Neurovascular Dysfunction and Glymphatic Impairment: An Unexplored Therapeutic Frontier in NeurodegenerationGhaith K Mansour, Olena Bolgova, Ahmad W Hajjar, et al.Biomedicines|December 30, 2025
Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of Its Pharmacological Profile, Clinical Utility, and Expanding ApplicationsGhaith K Mansour, Leen Alangari, Leen Khosyfan, et al.Frontiers in Pharmacology|August 22, 2025
Exploring dupilumab for asthma: from mechanistic insights to clinical outcomes, safety, and cost-effectivenessOmar Z Ameer, Ghaith K Mansour, Raghad S Al-Amoudi, et al.International Journal of Molecular Sciences|July 15, 2026
Xanomeline-Trospium Validates Muscarinic Agonism as an Effective Non-Dopaminergic Treatment for SchizophreniaGhaith K Mansour, Ahmad W Hajjar, Adnan H Hajjar, et al.Journal of Clinical Medicine|January 28, 2026
Anemia as a Potent and Underrecognized Driver of Venous Thromboembolism: A Systematic ReviewGhaith K Mansour, Walaa A Alshahrani, Lama Alfehaid, et al.Journal of Clinical Medicine|December 11, 2025
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Targeting Sarcomeric Hypercontractility with Demonstrated Long-Term Safety and Efficacy-A Narrative ReviewGhaith K Mansour, Ali F Altebainawi, Ahmad W Hajjar, et al.CNS Neuroscience & Therapeutics|April 8, 2026
The Viloxazine Paradox: A Noradrenergic Agent's Journey From Antidepressant Obscurity to ADHD Precision TherapyGhaith K Mansour, Sabry Babiker H Sayed, Sajjad Ghanim Al-Badri, et al.Pageof 2